These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16523380)

  • 21. Specific protein delivery to target cells by antibody-displaying bionanocapsules.
    Kurata N; Shishido T; Muraoka M; Tanaka T; Ogino C; Fukuda H; Kondo A
    J Biochem; 2008 Dec; 144(6):701-7. PubMed ID: 18838435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulations for delivery of therapeutic proteins.
    Stolnik S; Shakesheff K
    Biotechnol Lett; 2009 Jan; 31(1):1-11. PubMed ID: 18784904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma.
    Luk JM; Wong KF
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):482-8. PubMed ID: 16700883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systems approach to therapeutics design.
    Lao BJ; Kamei DT
    Methods Mol Biol; 2009; 500():221-36. PubMed ID: 19399427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering antibodies for clinical applications.
    Jain M; Kamal N; Batra SK
    Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of therapeutic proteins to the mucosa using genetically modified microflora.
    Steidler L
    Expert Opin Drug Deliv; 2005 Jul; 2(4):737-46. PubMed ID: 16296798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of osmotic pressure driven release of proteins from monolithic devices.
    Amsden B
    J Pharm Pharm Sci; 2007; 10(2):129-43. PubMed ID: 17706172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioengineering approaches to controlled protein delivery.
    Kobsa S; Saltzman WM
    Pediatr Res; 2008 May; 63(5):513-9. PubMed ID: 18427296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
    George M; Abraham TE
    J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New technologies for the engineering of novel protein therapeutics and the personalization of medicine.
    Dorner AJ; Projan S
    Curr Opin Pharmacol; 2008 Oct; 8(5):598-9. PubMed ID: 18773971
    [No Abstract]   [Full Text] [Related]  

  • 33. Cambridge Healthtech Institute's 4th Annual Recombinant Antibodies Conference.
    Casey JL; Coley AM
    Expert Opin Biol Ther; 2003 Aug; 3(5):859-62. PubMed ID: 12880385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous intracellular delivery of targeting antibodies and functional nanoparticles with engineered protein G system.
    Lim YT; Cho MY; Lee JM; Chung SJ; Chung BH
    Biomaterials; 2009 Feb; 30(6):1197-204. PubMed ID: 19056121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and characterization of biocompatible poly(organophosphazenes) aiming for local delivery of protein drugs.
    Seong JY; Jun YJ; Kim BM; Park YM; Sohn YS
    Int J Pharm; 2006 May; 314(1):90-6. PubMed ID: 16549280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparing and evaluating delivery systems for proteins.
    Jorgensen L; Moeller EH; van de Weert M; Nielsen HM; Frokjaer S
    Eur J Pharm Sci; 2006 Nov; 29(3-4):174-82. PubMed ID: 16828267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering protein particles for pulmonary drug delivery.
    Shoyele SA
    Methods Mol Biol; 2008; 437():149-60. PubMed ID: 18369967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics.
    Weisser NE; Hall JC
    Biotechnol Adv; 2009; 27(4):502-20. PubMed ID: 19374944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics--CHI's Fourth Annual Conference. 22-23 June 2000, San Francisco, CA, USA.
    Rapundalo S
    IDrugs; 2000 Oct; 3(10):1171-5. PubMed ID: 16049836
    [No Abstract]   [Full Text] [Related]  

  • 40. Protein engineering: The fate of fingers.
    Pearson H
    Nature; 2008 Sep; 455(7210):160-4. PubMed ID: 18784697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.